TAO SHEN to Hepatocytes
This is a "connection" page, showing publications TAO SHEN has written about Hepatocytes.
Connection Strength
1.019
-
Exosomes Derived From Bone Marrow Macrophages of HFD-Fed Mice Regulating AKT/GSK Pathway in Hepatocytes via miR-222-5p. FASEB J. 2026 Jan 15; 40(1):e71380.
Score: 0.215
-
Protein Phosphatase 4 Promotes Hepatocyte Lipoapoptosis by Regulating RAC1/MLK3/JNK Pathway. Oxid Med Cell Longev. 2021; 2021:5550498.
Score: 0.157
-
(+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis. Cell Death Dis. 2020 09 19; 11(9):781.
Score: 0.149
-
miR-338-3p mediates gluconeogenesis via targeting of PP4R1 in hepatocytes. Mol Med Rep. 2018 Oct; 18(4):4129-4137.
Score: 0.129
-
MiR-19a mediates gluconeogenesis by targeting PTEN in hepatocytes. Mol Med Rep. 2018 03; 17(3):3967-3971.
Score: 0.123
-
MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes. Sci Rep. 2015 Jun 26; 5:11602.
Score: 0.103
-
Efficient delivery of miR-122 to regulate cholesterol metabolism using a non-covalent peptide-based strategy. Mol Med Rep. 2013 Nov; 8(5):1472-8.
Score: 0.092
-
Protein phosphatase 4 (PP4) functions as a critical regulator in tumor necrosis factor (TNF)-a-induced hepatic insulin resistance. Sci Rep. 2015 Dec 15; 5:18093.
Score: 0.027
-
MiR-301a mediates the effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by regulating PTEN expression. Cell Physiol Biochem. 2015; 35(4):1413-24.
Score: 0.025